SEC Form 4 · accession 0001179110-19-000766
INVIVO THERAPEUTICS HOLDINGS CORP. · NVIV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard Christopher
Officer — CFO and Treasurer
Period of report
Jan 14, 2019
Accepted (ET)
Jan 16, 2019 · 4:41 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001292519
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nonstatutory Stock Option (right to buy)F1 | $1.53 | Jan 14, 2019 | A | 90,000 | A | — | Jan 13, 2029 | Common Stock | 90,000 | 90,000 | D |
Explanation of responses
- F1The shares underlying this option vest as to one-third (1/3) of the shares on January 14, 2020, one-third (1/3) of the shares on January 14, 2021 and the remaining one-third (1/3) of shares on January 14, 2022.